ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL1948A |
|
356559-13-2 |
SB-505124 hydrochloride 98+% |
C20H22ClN3O2 | |
CL1270A |
|
924898-09-9 |
Galunisertib monohydrate | LY2157299 monohydrate 98+% |
C22H19N5O.H2O | |
CLA1323 |
|
1356922-05-8 |
Bimagrumab (Anti-ACVR2B) 95+% |
— | |
CLA1157 |
|
705287-60-1 |
Stamulumab (Synonyms: MYO-029) 95+% |
— | |
CLA1151 |
|
272780-74-2 |
Metelimumab 95+% |
— | |
CLA1141 |
|
948564-73-6 |
Fresolimumab 95+% |
— | |
CL1270 |
|
700874-72-2 |
Galunisertib | LY2157299 98+% |
C22H19N5O | |
CL1082 |
|
301836-41-9 |
SB-431542 98+% |
C22H16N4O3 | |
CL1542 |
|
1062368-24-4 |
LDN-193189(DM3189) 98+% |
C25H22N6 | |
CL1057 |
|
1206711-16-1 |
DMH-1 (DMH1) 98+% |
C24H20N4O | |
CL1556 |
|
1432597-26-6 |
LDN-212854 | BMP Inhibitor III | LDN 212854 | 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline 98+% |
C25H22N6 | |
CL1900 |
|
700874-71-1 |
LY2109761 98+% |
C26H27N5O2 | |
CL1948 |
|
694433-59-5 |
SB-505124 98+% |
C20H21N3O2 | |
CL1007 |
|
446859-33-2 |
RepSox (Synonyms: E-616452; SJN 2511;ALK5 Inhibitor II) 98+% |
C17H13N5 | |